Prognostic Value of the 6-minute Stepper Test in Non-small Cell Lung Cancer Surgery (PREOTEST)

University Hospital, Rouen

Status: Completed

Conditions: Lung Neoplasm Malignant; Resectable Lung Non-Small Cell Carcinoma

Treatments: Diagnostic Test: Six minutes stepper test (6MST); Diagnostic Test: Sit to stand test (STST)

Study type: Observational

Funder types: Other

Identifiers

NCT03824977

2018-A02694-51

Details and patient eligibility

About

The objective of this study is to evaluate the performances of the Six-Minute Stepper Test (6MST) and Sit To Stand test (STST) to predict post-operative complications after minimally invasive lung cancer resection.

Enrollment: 122 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age >18
• Non-small cell lung cancer stage I to II, justifying major resection by VATS or RATS (segmentectomy, lobectomy, pneumonectomy), with or without histological confirmation

Exclusion criteria

• Partial or total amputation localized to the lower limb;
• Weight greater than 100 kg;
• Orthopedic, vascular or neurological disorders leading to the incapacity of realize the 6MST;
• Patient under tutorship or curatorship;
• Pregnant woman.
• Surgery canceled